Projects Supported by CIR3 (2023–2025)
 

Between 2023 and 2025, CIR3 provided financial support to several research projects aligned with its scientific and strategic priorities.

These projects reflect the diversity of the research activities supported and CIR3’s commitment to fostering the development and structuring of research.

Below is the list of projects supported during the 2023–2025 period, including the research title, project leader, and affiliated laboratory.

For 2023 :

ARTH-e 3 : Assessing the effectiveness of the ARTH-e application in improving adherence to physical exercises among patients with knee osteoarthritis, compared with standard care
Project Leader : Charlotte Lanhers – MPR
 

EXOCROHN : Exosomes as potential therapeutic agents in chronic inflammatory bowel diseases
Project Leader : Hang Nguyen –  M2iSH
 

FRAILTIES : Pre-Frailty sub-phenotype exploration by a multimodal approach
Project Leader : Blandine Comte – UNH
 

MUSCLECONNECT : Identification and characterization at the genomic level of a new muscle-connectivity pathway 
Project Leader : Cédric Soler –  GRED
 

PAINHIPSC : Phenotypic and functional screening of pain modulators
Project Leader : Jérôme Busserolles –  NEURO-DOL

For 2024 :

ASTROMIG : Astrocyte dysfunction drives chronic migraine
Project Leader : Radhouane Dallel – NEURO-DOL
 

CARSPECT II : Functional imaging of digital osteoarthritis and rheumatoid arthritis using 99mTc-NTP 15-5 in nuclear medicine: a phase II clinical study
Project Leader : Marion Chanchou – IMOST
 

DYSTROMIR1 : Assessing miR-1 role in DM1 pathogenesis and as biomarker of muscular dystrophies
Project Leader : Krzysztof Jagla – GRED
 

ESTEAM : Effects of hormonal status on muscle energy efficiency and eating behaviour in women
Project Leader : Lore Metz – AME2P
 

MITOCONDR : Mitochondrial adaptations of primary myoblasts conditioned with serum from COPD patients during pulmonary rehabilitation
Project Leader : Frederic Costes – CHU/UNH

PARADOL : Repurposing Paracetamol: Exploiting Its Mechanism of Action to Develop New Pharmacological Strategies Against Pain
Project Leader : Sylvie Ducki – ICCF
 

POWELL : Identification of the determinants and predictors (metabolic, energetic, endocrine, and functional) of adolescent mobility in the context of obesity: impact of the magnitude of weight variation
Project Leader : Laurie Isacco – AME2P

For 2025 :

AMYCCOE : Study of the metabolic state of adipose tissue during cancer-associated cachexia and chemotherapy on adipose tissue-skeletal muscle dialogue  
Project Leader : Johan Gagniere - CHU 
 

BODOX : Sondes Bodipy-quinonimine pour la détection d’enzymes oxydo-réductrices en HPTLC  
Project Leader : Clément Michelin – ICCF
 

EXMUS : Extracellular Modulators of MUScle specification and regeneration  
Project Leader : Charlène Guillot – iGRED
 

LYSOMP3 : Lysolipids targeting acid-sensing ion channel 3 in Musculoskeletal Pain PathoPhysiology  
Project Leader : Fabien Marchand – NEURO-DOL